|

CG009301 for Injection Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Cullgen (Shanghai),Inc1

Indications

  • MDS (Myelodysplastic Syndrome)1
  • Aml1
  • Leukemia1
  • AML (Acute Myelogenous Leukemia)1
  • MDS1

Other1 trial

A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.